Alessandra Borchiellini
Overview
Explore the profile of Alessandra Borchiellini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fianchi L, Bonanni M, Borchiellini A, Valeri F, Giuffrida G, Grasso S, et al.
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518700
: Immune thrombotic thrombocytopenic purpura (iTTP) is a thrombotic microangiopathy caused by the formation of anti-ADAMTS13 antibodies. Caplacizumab is approved for the treatment of acute episodes of iTTP in conjunction...
2.
Federici A, Santoro R, Santoro C, Pieri L, Santi R, Barillari G, et al.
Clin Appl Thromb Hemost
. 2024 Jul;
30:10760296241264541.
PMID: 39033425
Plasma-derived von Willebrand factor-containing factor VIII concentrates (pd-VWF/FVIII-C) are the mainstay of treatment in von Willebrand disease (VWD). Real-world data on efficacy and safety of these pd-VWF/FVIII-C are required. To...
3.
Dainese C, Valeri F, Bruno B, Borchiellini A
J Clin Med
. 2023 Sep;
12(17).
PMID: 37685697
Thrombotic thrombocytopenic purpura (TTP) is a fatal disease in which platelet-rich microthrombi cause end-organ ischemia and damage. TTP is caused by markedly reduced ADAMTS13 (a disintegrin and metalloproteinase with a...
4.
Sella C, Bardetta M, Valeri F, Dainese C, Valpreda A, Massaia M, et al.
J Clin Med
. 2023 Jul;
12(14).
PMID: 37510704
Background: Acquired hemophilia A (AHA) is a rare bleeding disease due to autoantibodies directed against clotting factor VIII (FVIII). Treatment of AHA consists of inhibitor eradication with immunosuppressive therapy (IST)...
5.
Palumbo G, Farruggia P, Ramenghi U, Russo G, Borchiellini A, Spinelli M, et al.
Hematology
. 2023 May;
28(1):2210906.
PMID: 37199369
Background: Immune thrombocytopenia (ITP) is the most common acquired bleeding disorder. In both children and adults, the primary goal of any therapeutic approach consists of cessation of bleeding and its...
6.
Tagliaferri A, Molinari A, Peyvandi F, Coppola A, Demartis F, Biasoli C, et al.
Haemophilia
. 2022 Nov;
29(1):135-144.
PMID: 36423202
Introduction: Factor IX replacement therapy is used for treatment and prophylaxis of bleeding in haemophilia B. rIX-FP is an extended half-life albumin-fusion protein, which, in clinical studies, has demonstrated prolonged...
7.
Dainese C, Valeri F, Bardetta M, Sella C, Porreca A, Valpreda A, et al.
Biomedicines
. 2022 Nov;
10(11).
PMID: 36359194
Both SARS-CoV-2 infection and vaccination have raised concern in immune-mediated diseases, including immune thrombocytopenic purpura (ITP) considering risk of de novo ITP development and ITP recurrence. Here, we report on...
8.
Pollio B, Ricca I, Dainese C, Valeri F, Valpreda A, Linari C, et al.
Acta Biomed
. 2022 Oct;
93(5):e2022293.
PMID: 36300218
Background: Haemophilia and von Willebrand disease are the bleeding disorders most frequently encountered in the emergency department (ED), that are often the first point of contact for patients. Evidence suggests...
9.
Dainese C, Valeri F, Pizzo E, Valpreda A, Sivera P, Montaruli B, et al.
Clin Appl Thromb Hemost
. 2022 Sep;
28:10760296221125785.
PMID: 36124377
The introduction Caplacizumab in the management of Immune thrombotic thrombocytopenic purpura (iTTP) has raised different questions, considering its cost-efficacy and the optimal immunosuppressive treatment (IST) to associate. A retrospective multicenter...
10.
Novembrino C, Quaglia I, Molinari A, Borchiellini A, Coppola A, Santoro R, et al.
Diagnostics (Basel)
. 2022 Aug;
12(8).
PMID: 36010349
Recombinant porcine factor VIII (rpFVIII) is indicated for treating bleeding episodes in acquired haemophilia A, but there are few data regarding laboratory methods to adequately monitor treatment. This study involving...